{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:27:01Z","timestamp":1777418821633,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ejphar.2004.02.018","type":"journal-article","created":{"date-parts":[[2004,3,20]],"date-time":"2004-03-20T11:11:47Z","timestamp":1079781107000},"page":"201-212","source":"Crossref","is-referenced-by-count":78,"title":["Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis"],"prefix":"10.1016","volume":"488","author":[{"given":"Nissar A.","family":"Darmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.02.018_BIB1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0028-3908(98)00208-1","article-title":"Modification of 5-HT2 receptor mediated behavior in the rat by oleamide and the role of cannabinoid receptors","volume":"38","author":"Cheer","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s007020050118","article-title":"Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis","volume":"105","author":"Darmani","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00197-4","article-title":"\u03949-Tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist\/inverse agonist SR 141716A","volume":"24","author":"Darmani","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"Delta-9-Tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01355-3","article-title":"The cannabinoid CB1 receptor SR 141716A antagonist reverses the antiemetic and motor depressant actions of WIN 55,212-2","volume":"430","author":"Darmani","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0091-3057(00)00477-9","article-title":"Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice","volume":"68","author":"Darmani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB9","series-title":"Biology of Marijuana: From Gene to Behavior","first-page":"356","article-title":"Antiemetic action of \u03949-tetrahydrocannabinol and synthetic cannabinoids in chemotherapy-induced nausea and vomiting","author":"Darmani","year":"2002"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB10","first-page":"247","article-title":"Long-term sequential determination of behavioral ontogeny of 5-HT1A and 5-HT2 receptor functions in the rat","volume":"288","author":"Darmani","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the selective cannabinoid CB1 receptor antagonist\/inverse agonist SR 141716A in naive mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(96)00072-X","article-title":"The mechanism by which the silent and selective 5-HT1A receptor antagonist (S-)UH 301 produces the 5-HT2A receptor-mediated head-twitch response in mice","volume":"55","author":"Darmani","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-9384(98)00174-7","article-title":"Production of serotonin syndrome by 8-OH DPAT in Cryptosis parva","volume":"65","author":"Darmani","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0091-3057(94)90542-8","article-title":"The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon","volume":"48","author":"Darmani","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(02)02815-7","article-title":"Antiemetic and motor depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution and G-protein activation","volume":"459","author":"Darmani","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(03)00150-3","article-title":"Behaviorally active doses of the CB1 receptor antagonist SR 141716A increases brain serotonin and dopamine levels and turnover","volume":"75","author":"Darmani","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.0022-3042.2002.00797.x","article-title":"Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum","volume":"80","author":"Devlin","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB18","first-page":"271","article-title":"Binding of amine-substituted and quaternary amine analogs of serotonin at 5-HT3 serotonin receptors","volume":"1","author":"Dukat","year":"1991","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.1985.tb10553.x","article-title":"Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan","volume":"85","author":"Endo","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/jn.1995.73.2.907","article-title":"Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurones","volume":"73","author":"Fan","year":"1995","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1254\/jjp.59.221","article-title":"Vagal afferent fibers and peripheral 5-HT receptors mediate cisplatin-induced emesis in dogs","volume":"59","author":"Fukui","year":"1992","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0028-3908(92)90154-H","article-title":"Effect of 5-hydroxy-l-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis","volume":"31","author":"Gartside","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB23","first-page":"695","article-title":"Antagonism of serotonin3 (5-HT3) receptors within the blood\u2013brain barrier prevents cisplatin-induced emesis in dogs","volume":"273","author":"Gidda","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0091-3057(92)90111-R","article-title":"5-HT3 agonist 2-methylserotonin as a training drug in discriminating studies","volume":"41","author":"Glennon","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0031-9384(89)90257-6","article-title":"Central versus peripheral effects on temperature preference and body temperature following alteration of 5-HT in maturing mice","volume":"46","author":"Goodrich","year":"1989","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB26","first-page":"414","article-title":"The modulation of head twitch behaviour by drugs acting on beta-adrenoceptors. Evidence for the involvement of both beta1- and beta2-adrenoceptors","volume":"89","author":"Handley","year":"1986","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01245006","article-title":"Positron emission tomographic studies on aromatic l-amino acid decarboxylase activity in vivo for l-dopa and 5-hydroxy-l-tryptophan in the monkey brain","volume":"94","author":"Hartvig","year":"1993","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine receptors in distinct neuronal subpopulations of the adult mouse brain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1254\/jjp.85.70","article-title":"Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus","volume":"85","author":"Horikoshi","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/jm00164a046","article-title":"5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin","volume":"33","author":"Ismaiel","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0704293","article-title":"Cannabinoid CB1 receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation","volume":"134","author":"Izzo","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0091-3057(01)00647-5","article-title":"Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by \u03949-THC and other cannabinoids","volume":"71","author":"Janoyan","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1248\/bpb.21.224","article-title":"Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytroptamine (5-HT) receptor","volume":"3","author":"Kimura","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB36","series-title":"Regulatory Mechanisms in Gastrointestinal Function","first-page":"277","article-title":"Hindbrain neuroactive substance controlling gastrointestinal functions","author":"Krowicki","year":"1995"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1254\/jjp.64.109","article-title":"Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus","volume":"64","author":"Okada","year":"1994","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1476-5381.1995.tb13293.x","article-title":"Blockade of motion- and cisplatin-induced emesis by a 5-HT2 receptor agonist in Suncus murinus","volume":"114","author":"Okada","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000057150","article-title":"Cannabis and cannabinoids: pharmacology and rationale clinical use","volume":"3","author":"Pertwee","year":"1999","journal-title":"Forsch. Komplement."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1054\/plef.2001.0345","article-title":"Endocannabinoids and the gut","volume":"66","author":"Pinto","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1054\/plef.2001.0356","article-title":"Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance","volume":"66","author":"Sugiura","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/gast.2001.28466","article-title":"Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret","volume":"121","author":"Van Sickle","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2165\/00003495-199753020-00003","article-title":"Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new drugs","volume":"53","author":"Veyrat-Follet","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2004.02.018_BIB46","first-page":"1159","article-title":"DAT-582, a novel 5-HT3 receptor antagonist, is a potent and long lasting antiemetic agent in the ferret and dog","volume":"260","author":"Yoshida","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.02.018_BIB47","unstructured":"Zhao, W., 1996. Characterization of drug-induced behaviors in Cryptotis parva (the least shrew). PhD thesis, Truman State University."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904001505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904001505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T09:24:40Z","timestamp":1550136280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904001505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":47,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0014299904001505"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.018","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}